Hey researcher, what are you reading?

Research / 23 October 2019

Photo: Eli Francis on Unsplash

A UMC researcher reviews a book that examines the French pharmacovigilance system through the eyes of patients affected by adverse drug reactions.

I’ve just finished a fascinating book, Effets indésirables: Victimes des médicaments (undesirable effects: victims of drugs) by French freelance journalist, Clotilde Cadu, which delves into the French pharmacovigilance system through the eyes of patients affected by adverse drug reactions. It’s not so often that we come across books on pharmacovigilance themes for a broader audience, so it’s nice to find one as well written as this. 

Effets indésirables: Victimes des médicaments

Effets indésirables: Victimes des médicaments

In Effets indésirables: Victimes des médicaments, Cadu revisits several cases of drug-related harm from recent French history from the point of view of the patients. She gives the patients a voice, telling what it was like for those affected by the drugs and how they were perceived and treated by doctors, pharmaceutical companies, and the legal system. 

As a researcher, used to dealing with case reports, scientific papers, and statistics, a book like this is an important reminder that there is a real person behind every data point. I believe that keeping that perspective is vital to the quality and relevance of our research. The better we understand what the patients are experiencing, the better we can do our job of improving their safety.


Read more:

Sarah Watson
Research Pharmacist, UMC

You may also like

UMC science gets personal

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Research / 16 March 2023

Optimising COVID-19 vaccine safety surveillance in the Netherlands

By utilising automated web reporting and a triage sorting system, the pharmacovigilance centre Lareb enabled near real-time processing of over 200 000 COVID-19 vaccine AEFI reports

Research / 27 March 2023

Unlocking the power of real-world data – New podcast episode

Real-world data is a rich source of evidence for pharmacovigilance, but there are challenges yet to be faced before unlocking its true potential as a resource.

Research / 31 March 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more